Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Cancer Vaccines, Identifying Druggable Targets

December 14, 2023 | 12:30 PM – 1:30 PM

Virtual

Add to Outlook Calendar

Learn about the cutting edge of computational immuno-oncology through a partnership between NCI and the Society for Immunotherapy of Cancer (SITC)!

In this webinar, NCI’s Dr. Charalampos Floudas and Moderna’s Dr. Wei Zheng will discuss:

  • therapeutic cancer vaccines,
  • different types of cancer vaccines, and
  • how to select antigen targets for cancer vaccines.

This SITC-NCI Computational Immuno-Oncology Webinar is the seventh course of eight, one-hour-long webinars designed to educate early-career scientists on computational immuno-oncology, increase participants’ awareness of and engagement in NCI-supported Cancer Moonshot SM Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.

Speakers

  1. Wei Zheng, Ph.D. is a senior director of cancer vaccine bioinformatics at Moderna.
  2. Charalampos S. Floudas, M.D., D.M.Sc., M.S. is a head and neck cancer medical oncologist and an assistant research physician for NCI’s Center for Cancer Research.
Email